Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "pharmaceutical sales"
Home
Beyond Cosmetics: Foreign Tourists Stock Up on Korean OTC Skin Ointments
Search TikTok for "must-buy items at Korean pharmacies," and a steady stream of video recommendations fills the screen.
09/21/2026, 22:29 ET
Zymfentra U.S. Sales Surge 176% as Celltrion’s Remsima Franchise Eyes 1 Trillion Won Annual Revenue
Biopharmaceutical company Celltrion announced on Aug. 27 that combined first-half sales of its subcutaneous infliximab products—Remsima SC and...
09/02/2026, 05:15 ET
South Korea Bans Pharmacies From Using 'Warehouse' or 'Factory' on Signage
Pharmacies in South Korea will no longer be allowed to use terms that evoke a “warehouse” or “factory” on their...
08/30/2026, 07:43 ET
Celltrion Files for South Korean Approval of Keytruda Biosimilar CT-P51
Celltrion announced on August 24 that it has submitted a marketing authorization application to South Korea’s Ministry...
08/28/2026, 23:36 ET
Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal
Hanmi Pharmaceutical has entered into an exclusive global licensing agreement with Genentech, a member of the Roche...
08/27/2026, 23:49 ET
Even Seoul-Area Tertiary Hospitals Fall Into the Red as 253 Institutions Record a Nine-Year Financial Slide
It is a familiar refrain in the healthcare industry that managing hospital finances has grown exceptionally difficult.
08/24/2026, 05:25 ET
Celltrion Secures Dominant Market Share in Asia Led by Autoimmune and Oncology Biosimilars
Celltrion is consolidating its leading market position across major Asian countries with its key autoimmune and...
08/20/2026, 01:54 ET
Courier-Delivered ‘Baekok Shots’ Were Actually Intended for Neurological Disorders
Some consumers have been purchasing prescription-only injectable drugs online without a doctor’s oversight.
08/18/2026, 04:29 ET
Samsung Bioepis Seeks South Korean Approval for Keytruda Biosimilar SB27
Samsung Bioepis announced on Aug. 10 that it has submitted a marketing authorization application to South Korea's...
08/13/2026, 11:04 ET
VOYXACT Preserves Kidney Function for Two Years in Phase 3 IgA Nephropathy Trial
Otsuka Pharmaceutical’s VOYXACT (active ingredient: sibeprenlimab) demonstrated long-term kidney protection by...
08/12/2026, 23:23 ET
Previous
1
2
3
4
Next